Raloxifene for postmenopausal osteoporosis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1998年 / 40卷 / 1022期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [21] Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
    Gorai, Itsuo
    Tanaka, Yaku
    Hattori, Shin
    Iwaoki, Yasuhisa
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (02) : 176 - 184
  • [22] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, T
    Liu, J
    Morii, H
    Huang, Q
    Zhu, H
    Qu, Y
    Hamaya, E
    Thiebaud, D
    BONE, 2005, 36 : S430 - S431
  • [23] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, Toshitaka
    Liu, Jian Li
    Morii, Hirotoshi
    Huang, Qi Ren
    Zhu, Han Min
    Qu, Yongming
    Hamaya, Etsuro
    Thiebaud, Daniel
    JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (05) : 414 - 418
  • [24] Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis
    Jochems, Caroline
    Islander, Ulrika
    Kallkopf, Anna
    Lagerquist, Marie
    Ohlsson, Claes
    Carlsten, Hans
    ARTHRITIS AND RHEUMATISM, 2007, 56 (10): : 3261 - 3270
  • [25] Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis
    Ensrud, K
    Genazzani, AR
    Geiger, MJ
    McNabb, M
    Dowsett, SA
    Cox, DA
    Barrett-Connor, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (04): : 520 - 527
  • [26] Effect of raloxifene hydrochloride on postmenopausal Japanese women with osteoporosis.
    Morii, H
    Orimo, H
    Taketani, Y
    Ishii, J
    Inoue, T
    Fujita, T
    Ohashi, Y
    Huster, WJ
    Lakshmanan, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T588 - T588
  • [27] Effect of raloxifene after teriparatide treatment in postmenopausal women with osteoporosis
    Adami, S.
    Munoz-Torres, M.
    Econs, M. J.
    Sipos, A.
    Xie, L.
    Dalsky, G. P.
    McClung, M.
    Felsenberg, D.
    Brown, J. P.
    Brandi, M. L.
    San Martin, J.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S137 - S137
  • [28] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Toshitaka Nakamura
    Jian Li Liu
    Hirotoshi Morii
    Qi Ren Huang
    Han Min Zhu
    Yongming Qu
    Etsuro Hamaya
    Daniel Thiebaud
    Journal of Bone and Mineral Metabolism, 2006, 24 : 414 - 418
  • [29] Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis
    Cranney, A
    Tugwell, P
    Zytaruk, N
    Robinson, V
    Weaver, B
    Adachi, J
    Wells, G
    Shea, B
    Guyatt, G
    ENDOCRINE REVIEWS, 2002, 23 (04) : 524 - 528
  • [30] Raloxifene is a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Jochems, C
    Islander, U
    Kallkopf, A
    Carlsten, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S161 - S161
12345